SEARCH HEALTH CONDITIONS BY ALPHABETS
Acute Lymphoblastic Leukemia
Medications for Acute Lymphoblastic Leukemia
About Acute Lymphoblastic Leukemia: Cancer of a particular kind of white blood cell called lymphocytes.
Drugs Used to Treat Acute Lymphoblastic Leukemia
The following listing of medications have been somehow related to, or utilized in the treatment of this particular condition.
Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
---|---|---|---|---|---|---|---|
methotrexate | Rx | X | N | X | Insert review | 0.0 | |
Generic name: methotrexate systemic Brand titles: Trexall, Xatmep Medication category: antimetabolites, Anti-rheumatics, antipsoriatics, other immunosuppressants For users: dosage, interactions, For specialists: A-Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
Gleevec | Rx | D | N | 1 review | 10 | ||
Generic name: imatinib systemic Drug class: BCR ABL tyrosine kinase inhibitors For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
mercaptopurine | Rx | D | N | Insert review | 0.0 | ||
Generic name: mercaptopurine systemic Brand titles: Purinethol, Purixan Medication class: antimetabolites For users: dosage, interactions, For specialists: A-Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
Sprycel | Rx | D | N | 1 review | 10 | ||
Generic name: dasatinib systemic Drug class: BCR ABL tyrosine kinase inhibitors For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
Adriamycin | Rx | D | N | Insert review | 0.0 | ||
Generic name: doxorubicin systemic Medication class: antibiotics/antineoplastics For users: dosage, interactions, side effects For specialists: Prescribing Information | |||||||
Blincyto | Rx | C | N | Insert review | 0.0 | ||
Generic name: blinatumomab systemic Medication class: amalgamated antineoplastics For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
pegaspargase | Rx | C | N | Y | Insert review | 0.0 | |
Generic name: pegaspargase systemic Brand name: Oncaspar Medication class: amalgamated antineoplastics For users: dosage, interactions, For specialists: A-Z Drug Truth, AHFS DI Monograph | |||||||
dasatinib | Rx | D | N | 1 review | 10 | ||
Generic name: dasatinib systemic Brand name: Sprycel Drug class: BCR ABL tyrosine kinase inhibitors For users: dosage, interactions, For specialists: A-Z Drug Truth, AHFS DI Monograph | |||||||
Trexall | Rx | X | N | X | Insert review | 0.0 | |
Generic name: methotrexate systemic Medication category: antimetabolites, Anti-rheumatics, antipsoriatics, other immunosuppressants For users: dosage, interactions, side effects For specialists: Prescribing Information | |||||||
Iclusig | Rx | D | N | 1 review | 1.0 | ||
Generic name: ponatinib systemic Drug class: multikinase inhibitors, BCR ABL tyrosine kinase inhibitors, and VEGF/VEGFR inhibitors For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
doxorubicin | Rx | D | N | Insert review | 0.0 | ||
Generic name: doxorubicin systemic Brand name: Adriamycin Medication class: antibiotics/antineoplastics For users: dosage, interactions, For specialists: A-Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
Purinethol | Rx | D | N | Insert review | 0.0 | ||
Generic name: mercaptopurine systemic Medication class: antimetabolites For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
imatinib | Rx | D | N | 1 review | 10 | ||
Generic name: imatinib systemic Brand name: Gleevec Drug class: BCR ABL tyrosine kinase inhibitors For users: dosage, interactions, For specialists: A-Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
Oncaspar | Rx | C | N | Y | Insert review | 0.0 | |
Generic name: pegaspargase systemic Medication class: amalgamated antineoplastics For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
asparaginase erwinia chrysanthemi | Rx | C | N | X | Insert review | 0.0 | |
Generic name: asparaginase erwinia chrysanthemi systemic Brand name: Erwinaze Medication class: amalgamated antineoplastics For users: dosage, interactions, For specialists: A-Z Drug Truth, AHFS DI Monograph | |||||||
Marqibo | Rx | D | N | Insert review | 0.0 | ||
Generic name: vincristine liposome systemic Drug class: mitotic inhibitors For users: dosage, interactions, side effects | |||||||
Xatmep | Rx | X | N | X | Insert review | 0.0 | |
Generic name: methotrexate systemic Medication course: antimetabolites, antirheumatics, other immunosuppressants For users: dosage, interactions, side effects For specialists: Prescribing Information | |||||||
ponatinib | Rx | D | N | 1 review | 1.0 | ||
Generic name: ponatinib systemic Brand name: Iclusig Drug class: multikinase inhibitors, BCR ABL tyrosine kinase inhibitors, and VEGF/VEGFR inhibitors For users: dosage, interactions, For specialists: A-Z Drug Truth, AHFS DI Monograph | |||||||
vincristine liposome | Rx | D | N | Insert review | 0.0 | ||
Generic name: vincristine liposome systemic Brand name: Marqibo Drug class: mitotic inhibitors For users: dosage, interactions, For specialists: A-Z Drug Truth | |||||||
blinatumomab | Rx | C | N | Insert review | 0.0 | ||
Generic name: blinatumomab systemic Brand name: Blincyto Medication class: amalgamated antineoplastics For users: dosage, interactions, For specialists: A-Z Drug Truth, AHFS DI Monograph | |||||||
Erwinaze | Rx | C | N | X | Insert review | 0.0 | |
Generic name: asparaginase erwinia chrysanthemi systemic Medication class: amalgamated antineoplastics For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
Clolar | Rx | D | N | Y | Insert review | 0.0 | |
Generic name: clofarabine systemic Medication class: antimetabolites For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
Arranon | Rx | D | N | Insert review | 0.0 | ||
Generic name: nelarabine systemic Medication class: antimetabolites For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
Besponsa | Rx | N | Insert review | 0.0 | |||
Generic name: inotuzumab ozogamicin systemic Medication class: amalgamated antineoplastics For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
clofarabine | Rx | D | N | Y | Insert review | 0.0 | |
Generic name: clofarabine systemic Brand name: Clolar Medication class: antimetabolites For users: dosage, interactions, For specialists: A-Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
Legend
Rx | Prescription Only |
---|---|
OTC | Over the Counter |
Rx/OTC | Prescription or Over The Counter |
Off Label | This medicine may not be approved by the FDA for treating this ailment. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to present a risk to the fetus in the first trimester of pregnancy (and there isn`t any evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to show a risk to the fetus and there are no adequate and well-controlled studies in elderly women. |
C | Animal reproduction studies have shown a negative effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify used in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with used in elderly women clearly outweigh potential rewards. |
N | FDA has not classified this medication. |
Controlled Substances Act (CSA) Program | |
---|---|
N | Is not subject to the Controlled Substances Act. |
1 | features a higher possibility of abuse. Has no accepted medical use in treatment in the USA. There is a lack of accepted safety for use under medical supervision. |
Two | features a higher possibility of abuse. Features a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the USA. Abuse may result in severe psychological or physical dependence. |
3 | Has a potential for abuse less than those in programs 1 and two. Features a currently accepted medical use in treatment in the USA. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | features a low potential for abuse relative to those in schedule 3. It`s a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence. |
5 | features a low potential for abuse relative to those in schedule 4. Features a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence. |
Infection | |
---|---|
X | Interacts with Medication. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Runciman
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always seek advice from with your physician to be sure the information relates to a circumstances.